Literature DB >> 10683510

Analysis of experimental autoimmune encephalomyelitis induced in F344 rats by pertussis toxin administration.

H Arimoto1, N Tanuma, Y Jee, T Miyazawa, K Shima, Y Matsumoto.   

Abstract

To elucidate the factor(s) accelerating the autoimmune disease processes, we induced two types of experimental autoimmune encephalomyelitis (EAE), severe and very mild, in F344 rats by immunization with myelin basic protein (MBP) plus pertussis toxin (PT) (PT+) or with MBP alone (PT-) and compared the differences between the two. Immunohistochemical examinations showed that although the nature of inflammation was essentially the same between the two groups, the proportion of Vbeta8.2(+) T cells in the CNS lesion of PT (+) rats was larger than that of PT (-) rats. Cytokine analysis by competitive PCR revealed that IL-10 mRNA in the lymphoid organ was significantly suppressed in the PT(+) group, whereas levels of IFN-gamma,TNF-alpha and TGF-beta mRNA were insignificantly different after PT administration. In addition, T cells taken from PT (+) rats proliferated well in response to MBP, while those from PT (-) rats showed a marginal response to the same antigen. However, this finding does not indicate the switching of non-encephalitogenic to encephalitogenic T cells upon PT administration because PT (-) rats contained encephalitogenic T cells and/or their precursor cells as revealed by adoptive transfer experiments. Taken together, these findings suggest that suppression of IL-10 by PT administration is the major factor contributing to the exacerbation of EAE in PT(+) rats.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10683510     DOI: 10.1016/s0165-5728(99)00242-8

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  8 in total

1.  Rodent models of experimental autoimmune uveitis.

Authors:  Rajeev K Agarwal; Phyllis B Silver; Rachel R Caspi
Journal:  Methods Mol Biol       Date:  2012

Review 2.  Contribution of pertussis toxin to the pathogenesis of pertussis disease.

Authors:  Nicholas H Carbonetti
Journal:  Pathog Dis       Date:  2015-09-21       Impact factor: 3.166

3.  Selective protection of murine cerebral Gi/o-proteins from inactivation by parenterally injected pertussis toxin.

Authors:  Salvador Castaneda Vega; Veronika Leiss; Roland Piekorz; Carsten Calaminus; Katja Pexa; Marta Vuozzo; Andreas M Schmid; Vasudharani Devanathan; Christian Kesenheimer; Bernd J Pichler; Sandra Beer-Hammer; Bernd Nürnberg
Journal:  J Mol Med (Berl)       Date:  2019-12-06       Impact factor: 4.599

4.  Role of Major Toxin Virulence Factors in Pertussis Infection and Disease Pathogenesis.

Authors:  Karen Scanlon; Ciaran Skerry; Nicholas Carbonetti
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

5.  Pertussis Toxin Exploits Specific Host Cell Signaling Pathways for Promoting Invasion and Translocation of Escherichia coli K1 RS218 in Human Brain-derived Microvascular Endothelial Cells.

Authors:  Sascha Karassek; Laura Starost; Johanna Solbach; Lilo Greune; Yasuteru Sano; Takashi Kanda; KwangSik Kim; M Alexander Schmidt
Journal:  J Biol Chem       Date:  2015-08-31       Impact factor: 5.157

6.  Suppression of the Peripheral Immune System Limits the Central Immune Response Following Cuprizone-Feeding: Relevance to Modelling Multiple Sclerosis.

Authors:  Monokesh K Sen; Mohammed S M Almuslehi; Erika Gyengesi; Simon J Myers; Peter J Shortland; David A Mahns; Jens R Coorssen
Journal:  Cells       Date:  2019-10-24       Impact factor: 6.600

7.  Repetitive pertussis toxin promotes development of regulatory T cells and prevents central nervous system autoimmune disease.

Authors:  Martin S Weber; Mahdia Benkhoucha; Klaus Lehmann-Horn; Deetje Hertzenberg; Johann Sellner; Marie-Laure Santiago-Raber; Michel Chofflon; Bernhard Hemmer; Scott S Zamvil; Patrice H Lalive
Journal:  PLoS One       Date:  2010-12-30       Impact factor: 3.240

8.  Pertussis Toxin Inhibits Encephalitogenic T-Cell Infiltration and Promotes a B-Cell-Driven Disease during Th17-EAE.

Authors:  Zahra Maria; Emma Turner; Agnieshka Agasing; Gaurav Kumar; Robert C Axtell
Journal:  Int J Mol Sci       Date:  2021-03-13       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.